Contract V797D70134
Alvogen, Inc. · Department Of Veterans Affairs · July 23, 2024
Alvogen, Inc. was awarded a federal contract by Department Of Veterans Affairs on July 23, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 6 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 4, 2026. If all options are exercised, the contract could reach $32.89 million.
Contract details
- PIID
- V797D70134
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- July 23, 2024
- Latest action
- February 4, 2026
Description
INCORPORATING THE PERMANENT FCP FOR ONE PRODUCT
Modification timeline
-
February 4, 2026Mod P00068 · Supplemental Agreement For Work Within Scope$0
-
December 2, 2025Mod P00067 · Supplemental Agreement For Work Within Scope2026 PUBLIC LAW$0
-
October 28, 2025Mod P00066 · Supplemental Agreement For Work Within ScopePRODUCT ADDITION$0
-
August 29, 2025Mod P00065 · Supplemental Agreement For Work Within ScopePRODUCT DESCRIPTION CHANGE$0
-
July 1, 2025Mod P00064 · Supplemental Agreement For Work Within ScopeTEMPORARY CONTRACT EXTENSION$0
-
September 25, 2024Mod P00059 · Supplemental Agreement For Work Within ScopeDELETION$0
-
July 23, 2024Mod P00058 · Supplemental Agreement For Work Within ScopeDELETION$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract V797D70134?
Contract V797D70134 is a federal contract awarded to Alvogen, Inc. by Department Of Veterans Affairs on July 23, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 6 times since the base award.
Who won contract V797D70134?
Alvogen, Inc. won contract V797D70134 from Department Of Veterans Affairs.
How much is contract V797D70134 worth?
Contract V797D70134 has obligated $0 to date but carries a potential ceiling of $32.89 million if fully funded and all options are exercised.